Accutane News and Research RSS Feed - Accutane News and Research

Accutane is a drug that belongs to the family of drugs called retinoids. It is used in the treatment of acne and psoriasis and is being studied in cancer prevention. Also called isotretinoin.
Not all acne bacteria trigger pimples: Study

Not all acne bacteria trigger pimples: Study

The bacteria that cause acne live on everyone's skin, yet one in five people is lucky enough to develop only an occasional pimple over a lifetime. [More]
National Birth Defects Prevention Network honors BU researcher with Godfrey P. Oakley, Jr., Award

National Birth Defects Prevention Network honors BU researcher with Godfrey P. Oakley, Jr., Award

Allen A. Mitchell, MD, a professor of public health (epidemiology) and professor of pediatrics at the Boston University Schools of Public Health and Medicine, recently received the Godfrey P. Oakley, Jr., Award at the annual meeting of the National Birth Defects Prevention Network. Mitchell, who is also the director of Boston University's Slone Epidemiology Center (SEC), was recognized for his significant lifetime contributions to the field of birth defects. [More]
FDA action results in shutdown of more than 18,000 illegal pharmacy websites

FDA action results in shutdown of more than 18,000 illegal pharmacy websites

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 4,100 Internet pharmacies that illegally sell potentially dangerous, unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products, and removal of offending websites. [More]
UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples. [More]
Acne pills can cause eye infections

Acne pills can cause eye infections

Millions of teenagers suffer from acne, and they deal with the embarrassing skin blemishes by taking popular prescription medications such as Accutane or Roaccutane. Now, however, research from Tel Aviv University shows that these pills can also cause eye infections such as conjunctivitis (pink eye) or sties. [More]

FDA, other regulatory and international partners complete International Internet Week of Action

The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products. [More]
New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

New UTHealth toll-free helpline for pregnant women to avoid dangerous medications

A new toll-free helpline developed to help pregnant women avoid medications and other substances that can cause birth defects has been launched by The University of Texas Health Science Center at Houston (UTHealth) for the Texas Department of State Health Services. [More]
Blocking interleukin 15 may help restore oral tolerance to gluten

Blocking interleukin 15 may help restore oral tolerance to gluten

Blocking a factor that can activate the human immune response against intestinal bacteria or certain foods could prevent the development of celiac disease in those most at risk, researchers report in the journal Nature. [More]

Acne, acne medicine and mental health: Study

Acne drug Accutane (isotretinoin) has been plagued by serious controversies with some linking it to suicidal tendencies. Now the latest research finds that severe acne itself increases the risk for suicidal thoughts and actions, raising more questions about the role of the drug, if any, in suicide. [More]

Severe acne linked to suicidal thoughts in teenagers

According to a new study on Norwegian youth, compared to clear-skinned peers, teens who have bad acne are more than twice as likely to have mental health problems and are at greater risk of having suicidal thoughts. [More]

Valocor Therapeutics acquires, licenses dermatology therapeutic programs from QLT

Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd. [More]

Teva reports 31% increase in non-GAAP net income for first-quarter 2010

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2010. [More]

New Jersey Superior Court links Roche's Accutane to IBD

In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties. [More]

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries Ltd. today reported record results for the quarter and year ended December 31, 2009. [More]

Hill Physicians Medical Group and MMC use RelayHealth’s referral management service

Hill Physicians Medical Group, one of the nation’s largest independent physician associations (IPAs) serving Northern California, and New York-based Montefiore Medical Center are using RelayHealth’s referral management service to facilitate secure health information exchange between primary care providers (PCP) and physician specialists. The result for both organizations is improved care team collaboration, patient satisfaction and specialty treatment prioritization. [More]

UBC acquires Gigamoto Technology Partners to implement risk management programs

United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk management programs for the life sciences industry. [More]
Sharing prescription advice among adolescents can have dangerous repercussions

Sharing prescription advice among adolescents can have dangerous repercussions

What if a teenager with acne who is taking Accutane - a drug linked to birth defects - gives some to her friend, who is pregnant but does not yet realize it? Unfortunately, this is a realistic scenario. [More]

Acne drug Roaccutane may disrupt serotonin production

New research has found that a drug used to treat severe forms of acne reduces the availability of the chemical serotonin, low levels of which have been linked to aggression and clinical depression. [More]

Report reveals pregnancies exposed to accutane despite iPledge

Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed. [More]

FDA discourages consumers from purchasing Accutane online

FDA last week launched a Web page aimed at discouraging consumers from purchasing the acne drug isotretinoin, sold by Roche under the brand name Accutane, on the Internet, Dow Jones/Marketwatch reports. [More]